Incyte to buy bleeding disorder biotech Vega Therapeutics in $1.25B upfront dealnews2026-06-08T11:03:56+00:00June 8th, 2026|Endpoints News|
Takeda says it expects to take $2.5B hit after Amitiza antitrust verdict, with plans to appealnews2026-06-08T11:01:03+00:00June 8th, 2026|Endpoints News|
Nurix to work with Roche on BTK degrader in pact worth up to $2.3Bnews2026-06-08T10:57:19+00:00June 8th, 2026|Endpoints News|
Warming seas impact cell structures that deliver oxygen to coralnews2026-06-08T08:34:00+00:00June 8th, 2026|Chemistry World|
Prospector AI Search, now powered by chemical intelligencenews2026-06-08T08:15:28+00:00June 8th, 2026|chemeurope.com|
